NuVasive Inc (NUVA):企業の財務・戦略的SWOT分析

◆英語タイトル:NuVasive Inc (NUVA) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1592
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:54
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

NuVasive Inc (NUVA) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

NuVasive Inc (NuVasive) is a medical device company that offers minimally invasive, procedurally-integrated spine solutions. The company principally provides Maximum Access Surgery (MAS), a minimally-disruptive surgical platform, which enables surgeons to perform a range of minimally-disruptive spine procedures in all regions of the spine and from various surgical approaches. Its MAS platform combines three product categories, namely, MaXcess retractors, its specialized implants and fixation products and its nerve monitoring systems and service offerings. The company’s offers implants, fixation products, intraoperative monitoring (IOM) services, disposables, and biologics for use in spinal surgery. NuVasive is headquartered in San Diego, California, the US.

NuVasive Inc Key Recent Developments

Apr 14,2020 NuVasive provides business update related to COVID-19
Feb 20,2020 NuVasive announces fourth quarter and full year 2019 financial results
Jan 13,2020 NuVasive announces preliminary unaudited fourth quarter and full year 2019 revenue results
Jan 02,2020 NuVasive appoints Matthew K. Harbaugh as chief financial officer

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
NuVasive Inc – Key Facts
NuVasive Inc – Key Employees
NuVasive Inc – Key Employee Biographies
NuVasive Inc – Major Products and Services
NuVasive Inc – History
NuVasive Inc – Company Statement
NuVasive Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
NuVasive Inc – Business Description
Product Category: Spinal Hardware
Overview
Performance
Product Category: Surgical Support
Overview
Performance
Geographical Segment: International (excluding Puerto Rico)
Performance
Geographical Segment: The US
Performance
R&D Overview
NuVasive Inc – Corporate Strategy
NuVasive Inc – SWOT Analysis
SWOT Analysis – Overview
NuVasive Inc – Strengths
NuVasive Inc – Weaknesses
NuVasive Inc – Opportunities
NuVasive Inc – Threats
NuVasive Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
NuVasive Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
NuVasive Inc, Medical Equipment, Deals By Type, 2014 to YTD 2020
NuVasive Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 14, 2020: NuVasive provides business update related to COVID-19
Feb 20, 2020: NuVasive announces fourth quarter and full year 2019 financial results
Jan 13, 2020: NuVasive announces preliminary unaudited fourth quarter and full year 2019 revenue results
Jan 02, 2020: NuVasive appoints Matthew K. Harbaugh as chief financial officer
Oct 30, 2019: NuVasive announces third quarter 2019 financial results
Aug 27, 2019: Alphatec announces favorable judgment in NuVasive v. Miles lawsuit
Aug 21, 2019: NuVasive: Departure of directors or certain officers
Aug 08, 2019: NuVasive presents long-term strategy and financial outlook at 2019 investor day
Jul 30, 2019: NuVasive announces second quarter 2019 financial results
May 30, 2019: Nuvasive SpineTRACK Registry successfully meets 2018 medicare reporting requirements for merit-based incentive payments system
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
NuVasive Inc, Key Facts
NuVasive Inc, Key Employees
NuVasive Inc, Key Employee Biographies
NuVasive Inc, Major Products and Services
NuVasive Inc, History
NuVasive Inc, Other Locations
NuVasive Inc, Subsidiaries
NuVasive Inc, Key Competitors
NuVasive Inc, Ratios based on current share price
NuVasive Inc, Annual Ratios
NuVasive Inc, Annual Ratios (Cont...1)
NuVasive Inc, Annual Ratios (Cont...2)
NuVasive Inc, Interim Ratios
NuVasive Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
NuVasive Inc, Medical Equipment, Deals By Type, 2014 to YTD 2020
NuVasive Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
NuVasive Inc, Performance Chart (2015 - 2019)
NuVasive Inc, Ratio Charts
NuVasive Inc, Medical Equipment, Deals By Year, 2014 to YTD 2020
NuVasive Inc, Medical Equipment, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[NuVasive Inc (NUVA):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Carlsberg Brewery Malaysia Berhad:戦略・SWOT・企業財務分析
    Carlsberg Brewery Malaysia Berhad - Strategy, SWOT and Corporate Finance Report Summary Carlsberg Brewery Malaysia Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Dyo Boya Fabrikalari Sanayi ve Tic. A.S. (DYOBY):企業の財務・戦略的SWOT分析
    Dyo Boya Fabrikalari Sanayi ve Tic. A.S. (DYOBY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key s …
  • GfK SE:企業の戦略・SWOT・財務情報
    GfK SE - Strategy, SWOT and Corporate Finance Report Summary GfK SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Chongqing Taiji Industry (Group) Co Ltd (600129):製薬・医療:M&Aディール及び事業提携情報
    Summary Chongqing Taiji Industry (Group) Co Ltd (Chongqing Taiji) is a provider of generic products. The company offers products such as traditional Chinese medicine, hospital products, OTC products, base products, and dietary supplement. It provides research and development, equipment, and manageme …
  • Corvia Medical Inc-医療機器分野:企業M&A・提携分析
    Summary Corvia Medical Inc (Corvia), formerly DC Devices Inc is a medical device company that offers structural heart disease solutions. The company develops interatrial shunt device (IASD), a trans-catheter device designed diastolic heart failure, also known as heart failure with preserved ejection …
  • Les Laboratoires Servier:企業の戦略・SWOT・財務情報
    Les Laboratoires Servier - Strategy, SWOT and Corporate Finance Report Summary Les Laboratoires Servier - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Firstsource Solutions Ltd (FSL):企業の財務・戦略的SWOT分析
    Firstsource Solutions Ltd (FSL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • DRDGOLD Ltd:企業の戦略・SWOT・財務情報
    DRDGOLD Ltd - Strategy, SWOT and Corporate Finance Report Summary DRDGOLD Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Nihon Kohden Corp (6849)-医療機器分野:企業M&A・提携分析
    Summary Nihon Kohden Corp (Nihon Kohden) is a provider of medical electronic equipment to support treatment in clinical areas of emergency response; testing, diagnosis, treatment, and rehabilitation. Its major products include patient monitors, electroencephalographs, evoked potential and electromyo …
  • Cimab SA-製薬・医療分野:企業M&A・提携分析
    Summary Cimab SA (Cimab) is a biopharmaceutical company that develops and markets monoclonal antibodies and other recombinant proteins for the diagnosis and treatment of cancer and other diseases related to the immune system. The company offers products such as cimaher nimotuzumab, ior epocim epoeti …
  • Samba Private Banking:企業の戦略・SWOT・財務情報
    Samba Private Banking - Strategy, SWOT and Corporate Finance Report Summary Samba Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Procter & Gamble SA Pty Ltd:企業の戦略的SWOT分析
    Procter & Gamble SA Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Manappuram Finance Limited (MANAPPURAM):企業の財務・戦略的SWOT分析
    Manappuram Finance Limited (MANAPPURAM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Ceapro Inc (CZO):製薬・医療:M&Aディール及び事業提携情報
    Summary Ceapro Inc (Ceapro) is a biotechnology company which develops proprietary extraction technologies for use in the production of extracts and active ingredients from oats and other renewable plant resources. The company’s extracts are also used in nutraceutical, cosmeceutical, and therapeutics …
  • The Hub Power Co Ltd:発電所・企業SWOT分析
    The Hub Power Co Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employee …
  • PetroChina Co Ltd (857)-石油・ガス分野:企業M&A・提携分析
    Summary PetroChina Company Limited (PetroChina), a subsidiary of China National Petroleum Corporation, is an oil and gas company that explores for, develops and produces crude oil and natural gas; refines crude oil and petroleum products; and produces and sells basic and derivative chemical products …
  • SmarTone Mobile Communications Ltd:企業の戦略的SWOT分析
    SmarTone Mobile Communications Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Blue Label Telecoms Ltd (BLU):企業の財務・戦略的SWOT分析
    Blue Label Telecoms Ltd (BLU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Rentokil Initial plc (RTO):企業の財務・戦略的SWOT分析
    Rentokil Initial plc (RTO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • MBNA Ltd:企業の戦略・SWOT・財務情報
    MBNA Ltd - Strategy, SWOT and Corporate Finance Report Summary MBNA Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆